It has been demonstrated that while higher levels of CD8+, CD4+, and CD3+ T cells in tumor stroma are associated with better overall survival (OS), FOXP3+ T cell infiltration leads to decreased OS in NSCLC patients [65,66]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.